Literature DB >> 23453972

Structure and ubiquitination-dependent activation of TANK-binding kinase 1.

Daqi Tu1, Zehua Zhu, Alicia Y Zhou, Cai-hong Yun, Kyung-Eun Lee, Angela V Toms, Yiqun Li, Gavin P Dunn, Edmond Chan, Tran Thai, Shenghong Yang, Scott B Ficarro, Jarrod A Marto, Hyesung Jeon, William C Hahn, David A Barbie, Michael J Eck.   

Abstract

Upon stimulation by pathogen-associated inflammatory signals, TANK-binding kinase 1 (TBK1) induces type I interferon expression and modulates nuclear factor κB (NF-κB) signaling. Here, we describe the 2.4 Å-resolution crystal structure of nearly full-length TBK1 in complex with specific inhibitors. The structure reveals a dimeric assembly created by an extensive network of interactions among the kinase, ubiquitin-like, and scaffold/dimerization domains. An intact TBK1 dimer undergoes K63-linked polyubiquitination on lysines 30 and 401, and these modifications are required for TBK1 activity. The ubiquitination sites and dimer contacts are conserved in the close homolog inhibitor of κB kinase ε (IKKε) but not in IKKβ, a canonical IKK that assembles in an unrelated manner. The multidomain architecture of TBK1 provides a structural platform for integrating ubiquitination with kinase activation and IRF3 phosphorylation. The structure of TBK1 will facilitate studies of the atypical IKKs in normal and disease physiology and further the development of more specific inhibitors that may be useful as anticancer or anti-inflammatory agents.
Copyright © 2013 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23453972      PMCID: PMC3863638          DOI: 10.1016/j.celrep.2013.01.033

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  52 in total

1.  IKK-i and TBK-1 are enzymatically distinct from the homologous enzyme IKK-2: comparative analysis of recombinant human IKK-i, TBK-1, and IKK-2.

Authors:  Nandini Kishore; Q Khai Huynh; Sumathy Mathialagan; Troii Hall; Sharon Rouw; David Creely; Gary Lange; James Caroll; Beverley Reitz; Ann Donnelly; Hymavathi Boddupalli; Rodney G Combs; Kuniko Kretzmer; Catherine S Tripp
Journal:  J Biol Chem       Date:  2002-02-11       Impact factor: 5.157

Review 2.  Signaling to NF-kappaB.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Genes Dev       Date:  2004-09-15       Impact factor: 11.361

3.  Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-kappaB-dependent gene transcription.

Authors:  M Bonnard; C Mirtsos; S Suzuki; K Graham; J Huang; M Ng; A Itié; A Wakeham; A Shahinian; W J Henzel; A J Elia; W Shillinglaw; T W Mak; Z Cao; W C Yeh
Journal:  EMBO J       Date:  2000-09-15       Impact factor: 11.598

4.  NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase.

Authors:  J L Pomerantz; D Baltimore
Journal:  EMBO J       Date:  1999-12-01       Impact factor: 11.598

5.  IKK-i, a novel lipopolysaccharide-inducible kinase that is related to IkappaB kinases.

Authors:  T Shimada; T Kawai; K Takeda; M Matsumoto; J Inoue; Y Tatsumi; A Kanamaru; S Akira
Journal:  Int Immunol       Date:  1999-08       Impact factor: 4.823

6.  Severe liver degeneration in mice lacking the IkappaB kinase 2 gene.

Authors:  Q Li; D Van Antwerp; F Mercurio; K F Lee; I M Verma
Journal:  Science       Date:  1999-04-09       Impact factor: 47.728

7.  A role for NF-kappaB essential modifier/IkappaB kinase-gamma (NEMO/IKKgamma) ubiquitination in the activation of the IkappaB kinase complex by tumor necrosis factor-alpha.

Authors:  Eric D Tang; Cun-Yu Wang; Yue Xiong; Kun-Liang Guan
Journal:  J Biol Chem       Date:  2003-07-16       Impact factor: 5.157

8.  Association of the adaptor TANK with the I kappa B kinase (IKK) regulator NEMO connects IKK complexes with IKK epsilon and TBK1 kinases.

Authors:  Alain Chariot; Antonio Leonardi; Jurgen Muller; Marianne Bonif; Keith Brown; Ulrich Siebenlist
Journal:  J Biol Chem       Date:  2002-07-19       Impact factor: 5.157

9.  IκB kinase ε phosphorylates TRAF2 to promote mammary epithelial cell transformation.

Authors:  Rhine R Shen; Alicia Y Zhou; Eejung Kim; Elgene Lim; Hasem Habelhah; William C Hahn
Journal:  Mol Cell Biol       Date:  2012-09-24       Impact factor: 4.272

10.  Bcl10 activates the NF-kappaB pathway through ubiquitination of NEMO.

Authors:  Honglin Zhou; Ingrid Wertz; Karen O'Rourke; Mark Ultsch; Somasekar Seshagiri; Michael Eby; Wei Xiao; Vishva M Dixit
Journal:  Nature       Date:  2003-12-24       Impact factor: 49.962

View more
  77 in total

1.  Zika virus NS5 protein antagonizes type I interferon production via blocking TBK1 activation.

Authors:  Shaoli Lin; Shixing Yang; Jia He; Johnathan D Guest; Zexu Ma; Liping Yang; Brian G Pierce; Qiyi Tang; Yan-Jin Zhang
Journal:  Virology       Date:  2018-12-06       Impact factor: 3.616

2.  Dengue virus subverts the interferon induction pathway via NS2B/3 protease-IκB kinase epsilon interaction.

Authors:  Yesseinia I Angleró-Rodríguez; Petraleigh Pantoja; Carlos A Sariol
Journal:  Clin Vaccine Immunol       Date:  2013-10-30

3.  Whole-genome sequencing reveals important role for TBK1 and OPTN mutations in frontotemporal lobar degeneration without motor neuron disease.

Authors:  Cyril Pottier; Kevin F Bieniek; NiCole Finch; Maartje van de Vorst; Matt Baker; Ralph Perkersen; Patricia Brown; Thomas Ravenscroft; Marka van Blitterswijk; Alexandra M Nicholson; Michael DeTure; David S Knopman; Keith A Josephs; Joseph E Parisi; Ronald C Petersen; Kevin B Boylan; Bradley F Boeve; Neill R Graff-Radford; Joris A Veltman; Christian Gilissen; Melissa E Murray; Dennis W Dickson; Rosa Rademakers
Journal:  Acta Neuropathol       Date:  2015-05-06       Impact factor: 17.088

4.  The E3 Ubiquitin Ligase TBK1 Mediates the Degradation of Multiple Picornavirus VP3 Proteins by Phosphorylation and Ubiquitination.

Authors:  Dan Li; Wenping Yang; Jingjing Ren; Yi Ru; Keshan Zhang; Shaozu Fu; Xiangtao Liu; Haixue Zheng
Journal:  J Virol       Date:  2019-11-13       Impact factor: 5.103

5.  SAMHD1 deficient human monocytes autonomously trigger type I interferon.

Authors:  Alicia Martinez-Lopez; Marta Martin-Fernandez; Sofija Buta; Baek Kim; Dusan Bogunovic; Felipe Diaz-Griffero
Journal:  Mol Immunol       Date:  2018-08-09       Impact factor: 4.407

6.  Methyltransferase Dnmt3a upregulates HDAC9 to deacetylate the kinase TBK1 for activation of antiviral innate immunity.

Authors:  Xia Li; Qian Zhang; Yuanyuan Ding; Yiqi Liu; Dezhi Zhao; Kai Zhao; Qicong Shen; Xingguang Liu; Xuhui Zhu; Nan Li; Zhongyi Cheng; Guoping Fan; Qingqing Wang; Xuetao Cao
Journal:  Nat Immunol       Date:  2016-05-30       Impact factor: 25.606

7.  Hantavirus interferon regulation and virulence determinants.

Authors:  Erich R Mackow; Nadine A Dalrymple; Velasco Cimica; Valery Matthys; Elena Gorbunova; Irina Gavrilovskaya
Journal:  Virus Res       Date:  2014-01-08       Impact factor: 3.303

Review 8.  Ubiquitination in the antiviral immune response.

Authors:  Meredith E Davis; Michaela U Gack
Journal:  Virology       Date:  2015-03-07       Impact factor: 3.616

9.  Inhibition of KRAS-driven tumorigenicity by interruption of an autocrine cytokine circuit.

Authors:  Zehua Zhu; Amir R Aref; Travis J Cohoon; Thanh U Barbie; Yu Imamura; Shenghong Yang; Susan E Moody; Rhine R Shen; Anna C Schinzel; Tran C Thai; Jacob B Reibel; Pablo Tamayo; Jason T Godfrey; Zhi Rong Qian; Asher N Page; Karolina Maciag; Edmond M Chan; Whitney Silkworth; Mary T Labowsky; Lior Rozhansky; Jill P Mesirov; William E Gillanders; Shuji Ogino; Nir Hacohen; Suzanne Gaudet; Michael J Eck; Jeffrey A Engelman; Ryan B Corcoran; Kwok-Kin Wong; William C Hahn; David A Barbie
Journal:  Cancer Discov       Date:  2014-01-20       Impact factor: 39.397

10.  Design, synthesis, and biological activity of substituted 2-amino-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxylic acid derivatives as inhibitors of the inflammatory kinases TBK1 and IKKε for the treatment of obesity.

Authors:  Tyler S Beyett; Xinmin Gan; Shannon M Reilly; Andrew V Gomez; Louise Chang; John J G Tesmer; Alan R Saltiel; Hollis D Showalter
Journal:  Bioorg Med Chem       Date:  2018-09-20       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.